| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 903,612 | 918,492 | 1,029,316 | 935,594 | | Cost of Revenue | 210,098 | 216,978 | 108,128 | 266,330 | | | Gross Profit | 693,514 | 701,514 | 921,188 | 669,264 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 69,587 | 67,946 | 201,140 | 45,650 | | Non Recurring | 140,478 |
-
| (17,367) | 17,367 | | Others | 258,751 | 269,352 | 292,937 | 222,552 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 224,698 | 364,216 | 444,478 | 383,695 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (21,172) | 4,252 | | Earnings Before Interest And Taxes | 230,335 | 372,284 | 536,780 | 364,048 | | Interest Expense | 244,443 | 226,036 | 244,933 | 239,955 | | Income Before Tax | (14,108) | 146,248 | 291,847 | 124,093 | | Income Tax Expense | (143) | (2,523) | 2,005 | 972 | | Minority Interest |
-
|
-
| 92,712 | (35,987) | | | | Net Income From Continuing Ops | (14,108) | 146,248 | 288,266 | 124,093 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (25) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,108) | 146,248 | 288,241 | 124,093 | | Preferred Stock And Other Adjustments | (6,652) | (39,480) | (143,038) | (11,284) | | | Net Income Applicable To Common Shares | ($20,760) | $106,768 | $145,203 | $112,809 |
|
2.03% Nasdaq 0.00%
Income Statement
